Grandview Asset Management LLC Eli Lilly & CO Transaction History

Grandview Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 10, 2024	BUY	$592.2 - $792.28 $134,429 - $179,847	227 Added 42.35%	763 $593,000
Q4 2023 Jan 11, 2024	BUY	$525.19 - $619.13 $281,501 - $331,853	536 New	536 $312,000
Q2 2021 Jul 21, 2021	SELL	$180.55 - $233.54 $27,804 - $35,965	-154 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$164.32 - $212.72 $24,483 - $31,695	149 Added 2980.0%	154 $29,000
Q1 2021 May 06, 2021	BUY	$164.32 - $212.72 $821 - $1,063	5 New	5 $10,000

4,004

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Grandview Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Grandview Asset Management LLC with notifications on news.